These findings were consistent with the prevalence of PLAC1 in luminal A and B breast cancer in comparison to TNBC [17], and that PLAC1 is among the top 1% of genes expressed 4-fold or more in subjects with invasive breast carcinoma [18]. This evidence concerns the gene PLAC1 and invasive breast carcinoma.